Purchases and Sales Made in Q1 2024 in Actinium Pharmaceuticals, Inc. (ATNM)
This table provides information about the institutional ownership of Actinium Pharmaceuticals, Inc. (ATNM) during Q1 2024. The information is specifically focused on institutions that hold shares of Actinium Pharmaceuticals, Inc..
| Report Date | Institution (Fund) | Operation | Option | Shares change | Value Range | Shares Held | Trade History |
|---|---|---|---|---|---|---|---|
|
May 15, 2024
Q1 2024
|
Bank Of America Corp
Charlotte, NC |
SELL
|
- |
-10.5K- 21.14% |
$52.4K - $96.3K
|
39.1K
$57.4K
|
|
|
May 15, 2024
Q1 2024
|
Barclays PLC
London, X0 |
SELL
|
- |
-18.3K- 48.65% |
$91.7K - $169K
|
19.4K
$28.5K
|
|
|
Oct 17, 2024
Q1 2024
|
Morgan Stanley
New York, NY |
SELL
|
- |
-23.3K- 24.8% |
$116K - $214K
|
70.7K
$104K
|
|
|
Aug 16, 2024
Q1 2024
|
Morgan Stanley
New York, NY |
SELL
|
- |
-28.9K- 29.02% |
$144K - $266K
|
70.7K
$104K
|
|
|
May 15, 2024
Q1 2024
|
Morgan Stanley
New York, NY |
SELL
|
- |
-28.9K- 29.02% |
$144K - $266K
|
70.7K
$104K
|
|
|
Apr 25, 2024
Q1 2024
|
Bank Of New York Mellon Corp
New York, NY |
SELL
|
- |
-47.4K- 41.32% |
$237K - $436K
|
67.4K
$99K
|
|
|
Jun 02, 2025
Q1 2024
|
Deutsche Bank Ag\
Frankfurt Am Main, 2M |
SELL
|
- |
-110K- 88.99% |
$548K - $1.01M
|
13.6K
$19.9K
|